Pfizer is using AI to match patients to clinical trials, aiming to make the process faster and more efficient.
Summaries like this, in your inbox every morning.
For example, today's edition would include:
AI-summarized, only the topics you pick: one digest a day via Email, LINE, or Slack.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
Applied Materials plans to invest US$5b in India over the next decade, building a 140 acre semiconductor resea…
In FY 2025, Lemonade posted revenue of nearly $737.9 million, up about 40.2%, but a net loss of close to $165.…
Microsoft launched a redesigned Copilot super app combining chat, coding tools, and a new Autopilot agentic fe…
Investor's Business Daily says AI memory chip stocks Micron Technology (MU), Sandisk (SNDK), SK Hynix (SKHY)…
The Motley Fool's comparison concluded ASML is the better buy over Qualcomm, citing its EUV machine monopoly a…
Broadcom introduced Symantec CBX, a tool that uses attack-trained AI to trace and predict attacks
